Ask Us
Please correct the highlighted fields below.

Alerts for Etanercept

Title Date Published Source
FDA Requires Closer Review of Adverse Event Reports for Tumor Necrosis Factor (TNF) Blockers 2011-11-04
FDA Updates Labels for Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), and Simponi (golimumab) 2011-09-07
FDA Continues to Receive Reports of Rare Cancer in Patients Treated With TNF Blockers, Azathioprine, and/or Mercaptopurine 2011-04-15
Recall of Several Lots of Enbrel (etanercept) SureClick Autoinjector, 50 mg/mL 2010-01-28
New Boxed Warning for Tumor Necrosis Factor (TNF) Blockers 2009-08-04
TNF Blockers Increase the Risk of Fungal Infections 2008-09-04
Early communication regarding cancer link in children 2008-06-04
New black box warning 2008-05-01

See alerts for all drugs